An eClinRO solution proven to deliver quality endpoint data
Set your study up for success with Signant Health’s eClinRO solution. It has delivered reliable endpoint data for more than 2,000 clinical trials ranging in size from 10 to 25,000 patients. It has been proven to significantly reduce rater errors in studies across multiple disorders by up to 80% (when compared to paper) and it has demonstrated a positive impact on placebo response, drug-placebo separation and effect sizes in multiple studies
Improves scale conduct and interview quality
Identifies data inconsistencies proactively
Evidence-based edit checks alert raters when an e-scale entry requires review and audio/visual captured interviews can be remotely reviewed by independent experts.
Why Choose Signant Health for eCOA/eClinRO?
Take advantage of the industry’s most advanced eClinRO capabilities to enhance data quality.
Scripting and logic is used to provide on-screen guidance and alerts to enforce administration conventions
Automated scoring is used whenever applicable
Evidence-based edit checks generate alerts prior to submission of completed scales
Integrated, secure audio/video of interviews can be captured and reviewed by remote, independent clinicians
Integration with Interactive Voice Response Systems (IVRS) can also be implemented to collect and score eligibility assessments based on your study’s unique criteria
The solution is accessed by raters via a provisioned tablet device. An online web application is available when appropriate.
Enhance Your eCOA/eClinRO Strategy
Get leading-edge tools for software design, training, and reporting, as well as clinical and scientific advisory services and a dedicated project management team to guide you—from study design to database lock. A complete list of services can be found on the eCOA solution page.
Computerized Cognitive Assessments
Signant’s CDR System® (Cognitive Drug Research System) is a widely used, extensively validated and highly sensitive computerized cognitive assessment battery. It has bi-directional sensitivity and comprises a range of tests assessing essential cognitive domains relevant to everyday life activities and was designed for repeated use in clinical trials and at all stages of clinical development.
What Our Experts Have to Say
TrialMax eClinRO enhances a clinical rater’s ability to administer high quality, reliable outcomes, improving the data integrity of complex CNS assessments. – Dan DeBonis, Principal
We’re Ready to Help with eClinRO
Learn how we can help improve your data collection in global clinical trials with a demo or speaking with one of our experts.